Lina Hallberg

Lina Hallberg is a highly experienced clinical operations professional with a strong background in managing clinical trials across various therapeutic areas, including rare diseases and kidney transplantation. Currently serving as the Clinical Operations Lead for Rare Disease at Novo Nordisk since September 2024, Lina has been instrumental in overseeing clinical trial startups from protocol development to recruitment. Prior roles include Team Lead and Senior Clinical Research Manager at Hansa Biopharma, where Lina led pivotal trials and managed a team of over 10 staff in clinical operations. With extensive project management experience at LINK Medical Research and TFS - Clinical Contract Research Organization, Lina has successfully managed global studies, ensuring compliance with regulatory standards and achievement of key milestones. Educational qualifications include multiple master's degrees in molecular biology from Lund University and the University of Washington, as well as prior experience in regulatory affairs.